Alex Arfaei


Alex joined Pappas Capital in 2019, bringing with him twelve years of equity research experience and six years of biopharma operating experience. Prior to joining Pappas, he was a Managing Director with BMO Capital Markets where he was a top-ranked senior equity research analyst responsible for pharmaceutical and biotechnology companies. Prior to joining BMO, Alex was an equity research associate at FBR. He began his career in the pharma industry with operating roles at Endo Pharmaceuticals and Merck, including positions in sales, market research, forecasting and product management.


University of Toronto (BSc in Cell and Molecular Biology)
Duke University Fuqua School of Business (MBA, Health Sector Management Concentration)